Alzheimer Disease

Contributing journals to this collection:
JAMA & Archives Journals

Citations 541-550 of 695 total displayed.

Past content

Editorials
New Biochemical Markers in Alzheimer Disease

Ramon Diaz-Arrastia; Fred Baskin
Arch Neurol 2001; 58: 354-356. [Extract] [Full text] [PDF]  

Basic Science Seminars in Neurology
Glutamate Transporters in Neurologic Disease

Nicholas J. Maragakis; Jeffrey D. Rothstein
Arch Neurol 2001; 58: 365-370. [Extract] [Full text] [PDF]  

Original Contributions
Evaluation of CSF-tau and CSF-Aß42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice

Niels Andreasen; Lennart Minthon; Pia Davidsson; Eugeen Vanmechelen; Hugo Vanderstichele; Bengt Winblad; Kaj Blennow
Arch Neurol 2001; 58: 373-379. [Abstract] [Full text] [PDF]  

Original Contributions
Ratio of 8-Hydroxyguanine in Intact DNA to Free 8-Hydroxyguanine Is Increased in Alzheimer Disease Ventricular Cerebrospinal Fluid

Mark A. Lovell; William R. Markesbery
Arch Neurol 2001; 58: 392-396. [Abstract] [Full text] [PDF]  

Original Contributions
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease

John C. Morris; Martha Storandt; J. Phillip Miller; Daniel W. McKeel; Joseph L. Price; Eugene H. Rubin; Leonard Berg
Arch Neurol 2001; 58: 397-405. [Abstract] [Full text] [PDF]  

Original Contributions
Mild Cognitive Impairments Predict Dementia in Nondemented Elderly Patients With Memory Loss

Andrea Bozoki; Bruno Giordani; Judith L. Heidebrink; Stanley Berent; Norman L. Foster
Arch Neurol 2001; 58: 411-416. [Abstract] [Full text] [PDF]  

Original Contributions
Response of Patients With Alzheimer Disease to Rivastigmine Treatment Is Predicted by the Rate of Disease Progression

Martin R. Farlow; Ann Hake; John Messina; Richard Hartman; Jeffrey Veach; Ravi Anand
Arch Neurol 2001; 58: 417-422. [Abstract] [Full text] [PDF]  

Original Contributions
Open-Label, Multicenter, Phase 3 Extension Study of the Safety and Efficacy of Donepezil in Patients With Alzheimer Disease

Rachelle S. Doody; David S. Geldmacher; Barry Gordon; Carlos A. Perdomo; Raymond D. Pratt; for the Donepezil Study Group
Arch Neurol 2001; 58: 427-433. [Abstract] [Full text] [PDF]  

Original Contributions
Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease

Sudha Seshadri; Gwen L. Zornberg; Laura E. Derby; Marian W. Myers; Hershel Jick; David A. Drachman
Arch Neurol 2001; 58: 435-440. [Abstract] [Full text] [PDF]  

Original Contributions
Amyloid Precursor Protein in Platelets of Patients With Alzheimer Disease: Effect of Acetylcholinesterase Inhibitor Treatment

Barbara Borroni; Francesca Colciaghi; Lucia Pastorino; Carla Pettenati; Elisabetta Cottini; Luca Rozzini; Roberto Monastero; Gian Luigi Lenzi; Flaminio Cattabeni; Monica Di Luca; Alessandro Padovani
Arch Neurol 2001; 58: 442-446. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70